CLINICAL_TRIALS
research
· 2026-04-17
Clinical Trial Update: A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants [Phase 1]
Summary
A Phase 1 bioequivalence study comparing two formulations of HRS-1893 tablets in healthy participants is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Cardiomyopathy | Phase 1 | Status: RECRUITING